SC 13G/A

ARCH VENTURE FUND IX, L.P. - LYELL IMMUNOPHARMA -- SCH 13G/A(#1)

Company: Lyell Immunopharma, Inc.
Filed: February 14, 2024
Accession Number: 0001072613-24-000252

View Document ↗ View on SEC.gov ↗